5-((6-(2,4-Bis(Trifluoromethyl)Phenyl)Pyridazin-3-Yl)Methyl)-2-(2-Fluorophenyl)-5H-Imidazo[4,5-C]Pyridine

Tegobuvir's primary application is in the treatment of Hepatitis C virus infections. Its role as a non-nucleoside inhibitor positions it as a crucial component in combination therapies aimed at improving treatment efficacy and minimizing resistance development. Clinical trials have evaluated its safety and effectiveness, particularly in patients who have not responded well to standard therapies.

The biological activity of Tegobuvir is characterized by its ability to inhibit HCV replication effectively. Studies have demonstrated that Tegobuvir displays potent antiviral effects against various HCV genotypes. Its unique mechanism allows it to circumvent some resistance mechanisms that are commonly seen with other antiviral agents, making it a promising candidate for combination therapies in treating chronic hepatitis C.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.